| Tissue-resident macrophages in pancreatic ductal adenocarcinoma originate from embryonic hematopoiesis and promote tumor progression Y Zhu, JM Herndon, DK Sojka, KW Kim, BL Knolhoff, C Zuo, DR Cullinan, ... Immunity 47 (2), 323-338. e6, 2017 | 702 | 2017 |
| Targeting tumour-associated macrophages with CCR2 inhibition in combination with FOLFIRINOX in patients with borderline resectable and locally advanced pancreatic cancer: a … TM Nywening, A Wang-Gillam, DE Sanford, BA Belt, RZ Panni, ... The lancet oncology 17 (5), 651-662, 2016 | 650 | 2016 |
| Murine dendritic cells pulsed with whole tumor lysates mediate potent antitumor immune responses in vitro and in vivo RC Fields, K Shimizu, JJ Mule Proceedings of the National Academy of Sciences 95 (16), 9482-9487, 1998 | 615 | 1998 |
| Driver fusions and their implications in the development and treatment of human cancers Q Gao, WW Liang, SM Foltz, G Mutharasu, RG Jayasinghe, S Cao, ... Cell reports 23 (1), 227-238. e3, 2018 | 476 | 2018 |
| Targeting both tumour-associated CXCR2+ neutrophils and CCR2+ macrophages disrupts myeloid recruitment and improves chemotherapeutic responses in pancreatic ductal adenocarcinoma TM Nywening, BA Belt, DR Cullinan, RZ Panni, BJ Han, DE Sanford, ... Gut 67 (6), 1112-1123, 2018 | 401 | 2018 |
| Cutaneous melanoma, version 2.2019, NCCN clinical practice guidelines in oncology DG Coit, JA Thompson, MR Albertini, C Barker, WE Carson, C Contreras, ... Journal of the National Comprehensive Cancer Network 17 (4), 367-402, 2019 | 377 | 2019 |
| The human tumor atlas network: charting tumor transitions across space and time at single-cell resolution O Rozenblatt-Rosen, A Regev, P Oberdoerffer, T Nawy, A Hupalowska, ... Cell 181 (2), 236-249, 2020 | 375 | 2020 |
| Dendritic cell paucity leads to dysfunctional immune surveillance in pancreatic cancer S Hegde, VE Krisnawan, BH Herzog, C Zuo, MA Breden, BL Knolhoff, ... Cancer cell 37 (3), 289-307. e9, 2020 | 309 | 2020 |
| Regional lymphadenectomy is indicated in the surgical treatment of pancreatic neuroendocrine tumors (PNETs) YM Hashim, KM Trinkaus, DC Linehan, SS Strasberg, RC Fields, D Cao, ... Annals of surgery 259 (2), 197-203, 2014 | 268 | 2014 |
| Surgical resection of the primary tumor is associated with increased long-term survival in patients with stage IV breast cancer after controlling for site of metastasis RC Fields, DB Jeffe, K Trinkaus, Q Zhang, C Arthur, R Aft, JR Dietz, ... Annals of surgical oncology 14, 3345-3351, 2007 | 268 | 2007 |
| Melanoma, version 2.2016, NCCN clinical practice guidelines in oncology DG Coit, JA Thompson, A Algazi, R Andtbacka, CK Bichakjian, ... Journal of the National Comprehensive Cancer Network 14 (4), 450-473, 2016 | 250 | 2016 |
| Tumor-on-a-chip platform to investigate progression and drug sensitivity in cell lines and patient-derived organoids VS Shirure, Y Bi, MB Curtis, A Lezia, MM Goedegebuure, ... Lab on a Chip 18 (23), 3687-3702, 2018 | 232 | 2018 |
| Systemic administration of interleukin 2 enhances the therapeutic efficacy of dendritic cell-based tumor vaccines K Shimizu, RC Fields, M Giedlin, JJ Mule Proceedings of the National Academy of Sciences 96 (5), 2268-2273, 1999 | 232 | 1999 |
| NCCN Guidelines® insights: melanoma: cutaneous, version 2.2021: featured updates to the NCCN guidelines SM Swetter, JA Thompson, MR Albertini, CA Barker, J Baumgartner, ... Journal of the National Comprehensive Cancer Network 19 (4), 364-376, 2021 | 196 | 2021 |
| Recurrence and survival in patients undergoing sentinel lymph node biopsy for merkel cell carcinoma: analysis of 153 patients from a single institution RC Fields, KJ Busam, JF Chou, KS Panageas, MP Pulitzer, DH Kraus, ... Annals of Surgical Oncology 18, 2529-2537, 2011 | 195 | 2011 |
| Breast and pancreatic cancer interrupt IRF8-dependent dendritic cell development to overcome immune surveillance MA Meyer, JM Baer, BL Knolhoff, TM Nywening, RZ Panni, X Su, ... Nature communications 9 (1), 1250, 2018 | 191 | 2018 |
| Transplantation versus resection for hilar cholangiocarcinoma: an argument for shifting treatment paradigms for resectable disease CG Ethun, AG Lopez-Aguiar, DJ Anderson, AB Adams, RC Fields, ... Annals of surgery 267 (5), 797-805, 2018 | 177 | 2018 |
| Rates and patterns of recurrence after curative intent resection for gastric cancer: a United States multi-institutional analysis G Spolverato, A Ejaz, Y Kim, MH Squires, GA Poultsides, RC Fields, ... Journal of the American College of Surgeons 219 (4), 664-675, 2014 | 172 | 2014 |
| Five hundred patients with Merkel cell carcinoma evaluated at a single institution RC Fields, KJ Busam, JF Chou, KS Panageas, MP Pulitzer, PJ Allen, ... Annals of surgery 254 (3), 465-475, 2011 | 171 | 2011 |
| Agonism of CD11b reprograms innate immunity to sensitize pancreatic cancer to immunotherapies RZ Panni, JM Herndon, C Zuo, S Hegde, GD Hogg, BL Knolhoff, ... Science translational medicine 11 (499), eaau9240, 2019 | 161 | 2019 |
William G. Hawkins MDWashington University School of MedicineVerified email at wustl.edu
